TRIL Is Involved in Cytokine Production in the Brain following Escherichia coli Infection
Author(s) -
Paulina Wochal,
Vijay Rathinam,
Aisling Dunne,
Thaddeus Carlson,
Wen Kuang,
Katherine J. Seidl,
J. Perry Hall,
LihLing Lin,
Mary Collins,
Stefan A. Schattgen,
Christopher R. MacKay,
Caio T. Fagundes,
Susan P. Carpenter,
Katherine A. Fitzgerald,
Luke O'neill
Publication year - 2014
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1302392
Subject(s) - tlr4 , tlr3 , chemokine , innate immune system , proinflammatory cytokine , biology , cytokine , immune system , escherichia coli infection , escherichia coli , immunology , in vivo , microbiology and biotechnology , mediator , inflammation , toll like receptor , gene , biochemistry
TLR4 interactor with leucine-rich repeats (TRIL) is a brain-enriched accessory protein that is important in TLR3 and TLR4 signaling. In this study, we generated Tril(-/-) mice and examined TLR responses in vitro and in vivo. We found a role for TRIL in both TLR4 and TLR3 signaling in mixed glial cells, consistent with the high level of expression of TRIL in these cells. We also found that TRIL is a modulator of the innate immune response to LPS challenge and Escherichia coli infection in vivo. Tril(-/-) mice produce lower levels of multiple proinflammatory cytokines and chemokines specifically within the brain after E. coli and LPS challenge. Collectively, these data uncover TRIL as a mediator of innate immune responses within the brain, where it enhances neuronal cytokine responses to infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom